These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38641602)

  • 1. Cervical cancer screening among women with comorbidities: evidence from the 2022 Tanzania demographic and health survey.
    Okyere J; Ayebeng C; Dosoo AK; Dickson KS
    BMC Public Health; 2024 Apr; 24(1):1093. PubMed ID: 38641602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
    Vigneshwaran E; Goruntla N; Bommireddy BR; Mantargi MJS; Mopuri B; Thammisetty DP; Veerabhadrappa KV; Bukke SPN
    BMC Cancer; 2023 Dec; 23(1):1216. PubMed ID: 38066496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25-49 years: evidence from the 2021 Côte d'Ivoire demographic and health survey.
    Okyere J; Ayebeng C; Dickson KS
    BMC Health Serv Res; 2024 Apr; 24(1):423. PubMed ID: 38570834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
    Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Hou L; Murphy RL; Adewole IF; Simon MA
    BMC Health Serv Res; 2018 Nov; 18(1):885. PubMed ID: 30466437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do vulnerable groups access prevention services? Cervical cancer screening and HIV testing among homeless migrant women in the Paris metropolitan area.
    Poncet L; Panjo H; Ringa V; Andro A
    PLoS One; 2021; 16(8):e0255900. PubMed ID: 34388200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial distribution and characteristics of women reporting cervical cancer screening in Malawi: An analysis of the 2020 to 2021 Malawi Population-based HIV Impact Assessment survey data.
    Twabi HH; Msosa TC; Meja SJ; Mukoka M; Semphere R; Chipungu G; Lissauer D; Odland ML; Tudor J; Msefula C; Nliwasa M
    PLoS One; 2024; 19(10):e0309053. PubMed ID: 39388421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socio-demographic determinants of cervical cancer screening uptake among women of child-bearing age in Mangochi, Malawi: a facility-based cross-sectional study.
    Mpachika-Mfipa F; Kululanga LI; Kazembe A; Mfipa D
    BMC Cancer; 2022 Oct; 22(1):1096. PubMed ID: 36289460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with age at first screening for cervical cancer among adult Cape Verdean women: a cross-sectional study.
    Okyere J; Ayebeng C; Dickson KS
    BMC Public Health; 2024 Sep; 24(1):2444. PubMed ID: 39251925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge, attitude, and practice of cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania.
    Kimondo FC; Kajoka HD; Mwantake MR; Amour C; Mboya IB
    Cancer Rep (Hoboken); 2021 Oct; 4(5):e1374. PubMed ID: 33739611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys.
    Okyere J; Duodu PA; Aduse-Poku L; Agbadi P; Nutor JJ
    BMC Public Health; 2021 Jun; 21(1):1071. PubMed ID: 34090372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating HIV testing into cervical cancer screening in Tanzania: an analysis of routine service delivery statistics.
    Plotkin M; Besana GV; Yuma S; Kim YM; Kulindwa Y; Kabole F; Lu E; Giattas MR
    BMC Womens Health; 2014 Sep; 14():120. PubMed ID: 25271025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
    Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
    BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wealth-related inequalities of women's knowledge of cervical cancer screening and service utilisation in 18 resource-constrained countries: evidence from a pooled decomposition analysis.
    Mahumud RA; Keramat SA; Ormsby GM; Sultana M; Rawal LB; Alam K; Gow J; Renzaho AMN
    Int J Equity Health; 2020 Mar; 19(1):42. PubMed ID: 32216799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening uptake and correlates among HIV-infected women: a cross-sectional survey in Côte d'Ivoire, West Africa.
    Tchounga B; Boni SP; Koffi JJ; Horo AG; Tanon A; Messou E; Koulé SO; Adoubi I; Ekouevi DK; Jaquet A
    BMJ Open; 2019 Aug; 9(8):e029882. PubMed ID: 31473620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanzanian women´s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017 - 2019.
    Henke A; Kluge U; Borde T; Mchome B; Serventi F; Henke O
    Glob Health Action; 2021 Jan; 14(1):1852780. PubMed ID: 33371824
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of uptake of cervical cancer screening among women in Urban Tanzania: community-based cross-sectional study.
    Mboineki JF; Wang P; Dhakal K; Getu MA; Millanzi WC; Chen C
    Int J Public Health; 2020 Dec; 65(9):1593-1602. PubMed ID: 33130908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of cervical cancer screening and its associated factors among women of child-bearing age in Mangochi district, Malawi: a facility-based cross-sectional study.
    Mpachika-Mfipa F; Kululanga LI; Mfipa D; Kazembe A
    BMC Womens Health; 2023 Jun; 23(1):334. PubMed ID: 37355588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and cervical cancer screening among women aged 15-69 years in Eswatini: evidence from a population-based survey.
    Motsa MPS; Estinfort W; Phiri YVA; Simelane MS; Ntenda PAM
    BMC Public Health; 2023 Aug; 23(1):1638. PubMed ID: 37635230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and geographic distribution of HIV-positive women diagnosed with cervical cancer in Dar es Salaam, Tanzania.
    Lovgren K; Soliman AS; Ngoma T; Kahesa C; Meza J
    Int J STD AIDS; 2016 Oct; 27(12):1049-1056. PubMed ID: 26464500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.
    Zhang D; Advani S; Huchko M; Braithwaite D
    BMJ Open; 2020 Jan; 10(1):e031823. PubMed ID: 31911515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.